TY - JOUR
T1 - Ubiquitination and proteolysis in acute lung injury
AU - Vadász, István
AU - Weiss, Curtis H.
AU - Sznajder, Jacob I.
N1 - Funding Information:
Funding/Support: Research in the authors' laboratories addressing ubiquitination was supported by the Deutsche Forschungsgemeinschaft [ Grant DFG/IRTG1062 ] to Drs Vadász and Sznajder, the University Medical Center Giessen and Marburg [ Grant 62589064 ] to Dr Vadász, and the National Institutes of Health [ Grants HL-71643, R37 48129, HL-85534, and HL-T32 76139 ] to Drs Weiss and Sznajder. Dr Vadász is supported by the Else Kröner Memorial Award, and Dr Weiss is the recipient of Parker B. Francis Fellowship.
PY - 2012/3
Y1 - 2012/3
N2 - Ubiquitination is a posttranslational modification that regulates a variety of cellular functions depending on timing, subcellular localization, and type of tagging, as well as modulators of ubiquitin binding leading to proteasomal or lysosomal degradation or nonproteolytic modifications. Ubiquitination plays an important role in the pathogenesis of acute lung injury (ALI) and other lung diseases with pathologies secondary to inflammation, mechanical ventilation, and decreased physical mobility. Particularly, ubiquitination has been shown to affect alveolar epithelial barrier function and alveolar edema clearance by targeting the Na,K-ATPase and epithelial Na+ channels upon lung injury. Notably, the proteasomal system also exhibits distinct functions in the extracellular space, which may contribute to the pathogenesis of ALI and other pulmonary diseases. Better understanding of these mechanisms may ultimately lead to novel therapeutic modalities by targeting elements of the ubiquitination pathway.
AB - Ubiquitination is a posttranslational modification that regulates a variety of cellular functions depending on timing, subcellular localization, and type of tagging, as well as modulators of ubiquitin binding leading to proteasomal or lysosomal degradation or nonproteolytic modifications. Ubiquitination plays an important role in the pathogenesis of acute lung injury (ALI) and other lung diseases with pathologies secondary to inflammation, mechanical ventilation, and decreased physical mobility. Particularly, ubiquitination has been shown to affect alveolar epithelial barrier function and alveolar edema clearance by targeting the Na,K-ATPase and epithelial Na+ channels upon lung injury. Notably, the proteasomal system also exhibits distinct functions in the extracellular space, which may contribute to the pathogenesis of ALI and other pulmonary diseases. Better understanding of these mechanisms may ultimately lead to novel therapeutic modalities by targeting elements of the ubiquitination pathway.
UR - http://www.scopus.com/inward/record.url?scp=84857973847&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84857973847&partnerID=8YFLogxK
U2 - 10.1378/chest.11-1660
DO - 10.1378/chest.11-1660
M3 - Article
C2 - 22396561
AN - SCOPUS:84857973847
SN - 0012-3692
VL - 141
SP - 763
EP - 771
JO - CHEST
JF - CHEST
IS - 3
ER -